Literature DB >> 22041231

Current concepts of surveillance and its significance in head and neck cancer.

Kapila Manikantan1, Raghav C Dwivedi, Suhail I Sayed, K A Pathak, Rehan Kazi.   

Abstract

Follow-up in head and neck cancer (hNC) is essential to detect and manage locoregional recurrence or metastases, or second primary tumours at the earliest opportunity. A variety of guidelines and investigations have been published in the literature. This has led to oncologists using different guidelines across the globe. The follow-up protocols may have unnecessary investigations that may cause morbidity or discomfort to the patient and may have significant cost implications. In this evidence-based review we have tried to evaluate and address important issues like the frequency of follow-up visits, clinical and imaging strategies adopted, and biochemical methods used for the purpose. This review summarises strategies for follow-up, imaging modalities and key investigations in the literature published between 1980 and 2009. A set of recommendations is also presented for cost-effective, simple yet efficient surveillance in patients with head and neck cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22041231      PMCID: PMC3566680          DOI: 10.1308/003588411X604794

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  51 in total

1.  CT surveillance of the thorax in patients with squamous cell carcinoma of the head and neck: a preliminary experience.

Authors:  V P Mercader; R A Gatenby; R M Mohr; M S Fisher; D F Caroline
Journal:  J Comput Assist Tomogr       Date:  1997 May-Jun       Impact factor: 1.826

2.  Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer.

Authors:  Frank E Johnson; Michael H Johnson; Marc F Clemente; Randal C Paniello; Katherine S Virgo
Journal:  Ann Surg Oncol       Date:  2006-06-21       Impact factor: 5.344

3.  Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer.

Authors:  K S Virgo; R C Paniello; F E Johnson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-05

4.  Thyroid function should be monitored following radiotherapy to the low neck.

Authors:  Allie Garcia-Serra; Robert J Amdur; Christopher G Morris; Ernest Mazzaferri; William M Mendenhall
Journal:  Am J Clin Oncol       Date:  2005-06       Impact factor: 2.339

5.  Echography of metastatic nodes treated by radiotherapy.

Authors:  A Ahuja; S F Leung; M Ying; C Metreweli
Journal:  J Laryngol Otol       Date:  1999-11       Impact factor: 1.469

6.  Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?

Authors:  Emmanuel Guardiola; Xavier Pivot; Olivier Dassonville; Gilles Poissonnet; Pierre-Yves Marcy; Josiane Otto; Michel Poudenx; Eric Francois; René-Jean Bensadoun; Antoine Thyss; François Demard; Maurice Schneider
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

7.  The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer.

Authors:  P C Lara; J M Cuyás
Journal:  Cancer       Date:  1995-09-01       Impact factor: 6.860

8.  Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.

Authors:  Arie Gordin; Marcello Daitzchman; Ilana Doweck; Nikolay Yefremov; Avishay Golz; Zohar Keidar; Rachel Bar-Shalom; Abraham Kuten; Ora Israel
Journal:  Laryngoscope       Date:  2006-02       Impact factor: 3.325

Review 9.  A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.

Authors:  M G Isles; C McConkey; H M Mehanna
Journal:  Clin Otolaryngol       Date:  2008-06       Impact factor: 2.597

10.  The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer.

Authors:  L Rachmat; G C Vreeburg; N de Vries; G J Hordijk; H Lubsen; J J Manni; G B Snow
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

View more
  5 in total

1.  [CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck].

Authors:  R M W Rödel; H Christiansen
Journal:  Strahlenther Onkol       Date:  2012-09       Impact factor: 3.621

Review 2.  Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.

Authors:  Antoine Digonnet; Marc Hamoir; Guy Andry; Missak Haigentz; Robert P Takes; Carl E Silver; Dana M Hartl; Primož Strojan; Alessandra Rinaldo; Remco de Bree; Andreas Dietz; Vincent Grégoire; Vinidh Paleri; Johannes A Langendijk; Vincent Vander Poorten; Michael L Hinni; Juan P Rodrigo; Carlos Suárez; William M Mendenhall; Jochen A Werner; Eric M Genden; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-13       Impact factor: 2.503

3.  Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.

Authors:  Lei Jin; Erich M Sturgis; Yang Zhang; Zhigang Huang; Peng Wei; Wei Guo; Zhongqiu Wang; Qingyi Wei; Xicheng Song; Guojun Li
Journal:  Carcinogenesis       Date:  2013-03-18       Impact factor: 4.944

Review 4.  Post-therapeutic surveillance schedule for oral cancer: is there agreement?

Authors:  Guicai Liu; Eric J Dierks; R Bryan Bell; Tuan G Bui; Bryce E Potter
Journal:  Oral Maxillofac Surg       Date:  2012-09-02

Review 5.  Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience.

Authors:  Nerina Denaro; Marco Carlo Merlano; Elvio Grazioso Russi
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-06-25       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.